Haploidentical hematopoietic cell transplantation is even more advantageous during the COVID‐19 pandemic
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Transplantation"
DOI: 10.1111/petr.14004
Abstract: To the Editor The SARSCoV2 has overwhelmed healthcare systems worldwide. Hematopoietic cell transplantation (HCT) has been uniquely affected as this virus may not only severely impact the immunocompromised recipient but also the potential stem cell… read more here.
Keywords: sarscov2; serology; cell transplantation; hematopoietic cell ... See more keywords
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-222115
Abstract: Monoclonal antibodies (MAbs), convalescent plasma (CP) and hyperimmune intravenous immunoglobulins are routinely used to treat COVID19 patients with autoimmune disorders, organ transplant patients and patients on immunosuppressive drugs. The recent emergence of rapidly spreading SARSCoV2… read more here.
Keywords: omicron; neutralisation; sarscov2; neutralisation titres ... See more keywords
High antibody response in relation to immunosuppressive blood levels in liver transplant recipients after SARS-CoV-2 vaccination: an observational, cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Gut"
DOI: 10.1136/gutjnl-2021-326755
Abstract: We read with great interest the recent publication from Siegel and colleagues, reporting recommendations from an international consensus meeting for SARSCoV2 vaccination in patients with inflammatory bowel diseases (IBDs). Based on experiences with other vaccines,… read more here.
Keywords: rotterdam netherlands; erasmus university; vaccination; sarscov2 ... See more keywords